## Abstract A patient with melanoma was found to have lymphocytes highly cytotoxic for autogenous tumor cells but not for fibroblasts. Autogenous serum did not block the cytotoxicity. He then received an injection of BCG into a small tumor nodule. Three weeks later, in association with accelerated
Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity
✍ Scribed by Ingegerd Hellström; Karl Erik Hellström; Hans Olov Sjögren; Glenn A. Warner
- Publisher
- John Wiley and Sons
- Year
- 1971
- Tongue
- French
- Weight
- 486 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
It has been previously shown that lymphocytes from cancer patients can kill cultivated neoplastic cells of the type carried by the lymphocyte donors and that sera from patients with growing tumors of the respective types can specifically block the tumor‐cell destruction. The present study demonstrates that sera from all of seven tumor patients tested (one with melanoma, one with colonic carcinoma and four with breast carcinoma), who had become clinically tumor‐free, could “unblock” ( = abrogate) the blocking effect of sera from patients bearing tumors of the respective types, thus making it possible for immune lymphocytes to kill cultivated neoplastic cells in the combined presence of the “unblocking” and blocking sera.
📜 SIMILAR VOLUMES
## Abstract Immunity against transplantation of MM2 cells, an ascites cell line of mouse mammary carcinoma, was induced in syngeneic C3H/He mice by intraperitoneal injection of a complex formed between a MM2‐specific cell surface component isolated from the cells and a serum factor found in the ser
The responsiveness of lymphocytes obtained from patients with brain tumors to in vitro stimulation with mitogenic lectins was examined. The previously reported finding of decreased responsiveness was confirmed. To investigate the factors responsible for the hyporesponsiveness, mitogen (phytohemagglu